Ascendiant
Share
Ascendiant’s experienced investment banking team has initiated and closed more than 300 M&A transactions over the last 20 years in a broad range of industries.
Funding public companies is what we do. Ascendiant has led or participated in over $2 billion in financing transactions. We’ve invested our own capital over the years and have relationships with institutional and strategic investors seeking quality opportunities.
03/14/2023
Another successful M&A Transaction and positive feedback associated with Ascendiant Managing Director, Bill Peck!
02/16/2023
Ascendiant Capital Markets LLC (“Ascendiant”) announced today the closing of a $12,040,000 Public Offering for SINTX Technologies, Inc. (Nasdaq: SINT) of Salt Lake City, Utah.
Ascendiant served as the Financial Advisor on the transaction. For a copy of this announcement, please click the link below.
https://cdn.aelieve.com/abf08a56-ascendiant-sint-feb23-announcement-february-2023.pdf
02/14/2023
Ascendiant Capital Markets, LLC announced today the initiation of research coverage on BioSig Technologies, Inc. (Nasdaq: BSGM) of Westport, Connecticut.
For a copy of the initiation report, please click the link below.
https://cdn.aelieve.com/602f68f8-bsgm-2023.02.12-coverage-initiation.pdf
02/09/2023
When an investment bank requires exclusivity or a Right of First Refusal (ROFR) following a capital raise, they are adding leverage to the relationship and limiting your Company’s options. When you work with us, you have freedom, and that’s best for your business.
02/02/2023
Grateful for the positive feedback - it’s been a pleasure supporting Robert Liscouski and the team at Quantum Computing Inc. (Nasdaq: QUBT)!
01/31/2023
Ascendiant Capital Markets, LLC announced today the initiation of research coverage on Heart Test Laboratories, Inc. (Nasdaq: HSCS) of Southlake, Texas.
For a copy of the initiation report, please click the link below.
https://ascendiant.com/research-reports/company/heart-test-laboratories-inc/
01/26/2023
Ascendiant Capital Markets LLC announced today its role as Sole Agent on the Stock Repurchase Plan of up to $5,000,000 for Phunware, Inc. (Nasdaq: PHUN) of Austin, Texas.
For a copy of the announcement, please visit the link below:
https://cdn.aelieve.com/23db8190-ascendiant-phun-buyback-announcement-jan-2023.pdf
01/25/2023
Ascendiant Capital Markets LLC announced today the filing of a $3,500,000 At-the-Market (ATM) Offering for Ecoark Holdings, Inc. (Nasdaq: ZEST) of San Antonio, Texas.
Ascendiant is serving as Sole Sales Agent on the financing transaction.
For a copy of the announcement, please visit the link below:
https://cdn.aelieve.com/8008c2f8-ascendiant-zest-atm-announcement-jan-2023.pdf
01/19/2023
Ascendiant Capital Markets, LLC announced today the initiation of research coverage on Duos Technologies Group, Inc. (Nasdaq: DUOT) of Jacksonville, Florida.
For a copy of the initiation report, please click the link below.
https://cdn.aelieve.com/8bc9412e-duot-2023.01.18-coverage-initiation.pdf
01/17/2023
Ascendiant Capital Markets, LLC announced today the initiation of research coverage on Vivos Therapeutics, Inc. (Nasdaq: VVOS) of Littleton, Colorado.
For a copy of the initiation report, please click the link below.
https://cdn.aelieve.com/57cdf9c5-vvos-2023.01.17-coverage-initiation.pdf
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
110 Front Street, Suite 300
Jupiter, FL
33477